Medical News

RSS

First anniversary of Capital BlueCross' Accountable Care Arrangement programs

Today marks the one-year anniversary of Capital BlueCross' launch of two Accountable Care Arrangements (ACA). Preliminary results demonstrate that this innovative care delivery model is improving care coordination, lowering the medical cost trend, and improving the member's management of chronic conditions and overall satisfaction with care.

2 May 2012

Misleading information about breast brachytherapy

One of the leading experts on radiation therapy for breast cancer says a new study in JAMA -- about breast cancer treatment - has misleading information and may unnecessarily deter women from getting breast brachytherapy, a safe and effective treatment.

2 May 2012

Health Care REIT completes acquisition with Chartwell Seniors Housing REIT

Health Care REIT, Inc. announced today that it has completed the acquisition with Chartwell Seniors Housing REIT of 42 seniors housing and care communities in attractive Canadian markets, which was previously announced on February 15, 2012.

2 May 2012

Kindred Healthcare first quarter consolidated revenues increase 33% to $1.6 billion

Kindred Healthcare, Inc. today announced its operating results for the first quarter ended March 31, 2012. The Company's consolidated financial statements include the operating results of RehabCare Group, Inc. since the closing of the acquisition on June 1, 2011.

2 May 2012

German BfArM grants Moberg Derma approval to initiate Limtop phase II actinic keratosis trial

The German Federal Institute for Drugs and Medical Devices (BfArM) has granted Moberg Derma approval to initiate a clinical phase II trial for Limtop. The aim is to evaluate the efficacy and safety of three different dose regimens of Limtop in a study involving 96 patients with Actinic Keratosis (AK) on the head or face.

2 May 2012

Levetiracetam to be tested for seizure management in malaria endemic regions

Michigan State University researchers, with the help of a groundbreaking medical device, are starting a clinical trial in Africa they hope will provide relief for the hundreds of thousands of children who survive cerebral malaria but are left stricken with epilepsy or other neurologic disorders.

2 May 2012

Optimum blood vitamin D levels to reduce risk of major medical events

In testing older patients' blood vitamin D levels, there's uncertainty about where the dividing line falls between enough and not enough. The threshold amount has become controversial as several scientific societies set different targets.

2 May 2012

It's never too late to take control of diabetes

"You could live a normal life." Those were the words that 15-year-old Steve Edelman kept hearing from the nurses when he was hospitalized following his type 1 diabetes diagnosis in 1970. He wondered why they kept repeating this to him.

2 May 2012

Online assessment tool for stroke

Nearly 800,000 Americans will suffer a stroke this year, yet most people in the U.S. cannot identify stroke warning signs or risk factors. HealthONE Stroke Care hopes to change that during May's National Stroke Awareness Month with the introduction of its new Stroke Risk Profiler, an online assessment tool for adults of all ages

2 May 2012

Grape-derived compound may prevent neurodegenerative disorders involving tau neuropathology

Researchers at Mount Sinai School of Medicine have gained insight into the mechanism by which a pathological brain protein called tau contributes to the progression of Alzheimer's disease (AD) and other neurodegenerative disorders. This finding, published in the most recent issue of the Journal of Biological Chemistry, may provide the basis for future investigations on how to prevent tau from damaging brain circuits involved in cognitive function.

2 May 2012

Biosynthetic polyphenol may improve cognitive function in Alzheimer's disease patients

Mount Sinai School of Medicine researchers have succeeded in developing a biosynthetic polyphenol that improves cognitive function in mice with Alzheimer's disease (AD). The findings, published in a recent issue of the Journal of Neuroscience, provide insight in determining the feasibility of biosynthetic polyphenols as a possible therapy for AD in humans, a progressive neurodegenerative disease for which there is currently no cure.

2 May 2012

Medical Brands' cranberry-based oral capsule granted Class IIa medical device status

Medical Brands has obtained a Class IIa medical device status through the appropriate Competent Authorities for Cranberry-Active, a patented cranberry-based oral capsule clinically shown to support urinary tract health.

2 May 2012

ImmuVen awarded $1.68M NIH Phase II SBIR grant to develop IMV0123

ImmuVen was awarded a Phase II Small Business Innovation Research (SBIR) grant totaling $1.68 million from the National Institute for Allergy and Infectious Disease (NIH) for continuing development of its therapeutic pipeline (IMV0123) against superantigens produced by methicillin-sensitive and methicillin-resistant Staphylococcal aureus.

2 May 2012

Older Americans experience significant and troubling gaps in primary care

Large majorities of older Americans experience significant and troubling gaps in their primary care, according to a new national survey, "How Does It Feel? The Older Adult Health Care Experience," released today by the John A. Hartford Foundation, a champion for improved geriatric care and longtime partner of the Hartford Institute for Geriatric Nursing at New York University's College of Nursing.

2 May 2012

Expression of tyrosine kinases may limit effectiveness of agents against sarcomas

To better understand the signaling pathways active in sarcomas, researchers at Moffitt Cancer Center used state-of-the-art mass spectrometry-based proteomics to characterize a family of protein enzymes that act as "on" or "off" switches important in the biology of cancer. The tyrosine kinases they identified, the researchers said, could act as "drivers" for the growth and survival of sarcomas.

2 May 2012

Nanocomposite dental cavity-filling kills harmful bacteria

Scientists using nanotechology at the University of Maryland School of Dentistry have created the first cavity-filling composite that kills harmful bacteria and regenerates tooth structure lost to bacterial decay.

2 May 2012

Lobbyists drive up taxpayer costs by obstructing state efforts to reform Medicaid drug programs

By obstructing state efforts to reform Medicaid drug programs, lobbyists drive up taxpayer costs, according to a new study by the National Center for Policy Analysis (NCPA).

2 May 2012

Acute need for more effective treatments for pediatric obesity

With nearly one-third of American children being overweight or obese, doctors agree that there is an acute need for more effective treatments. In many weight management programs, the dropout rate can be as high as 73 percent, and even in successful programs, the benefits are usually short term.

2 May 2012

Solta Medical first quarter revenue increases 23% to $32.5 million

Solta Medical, Inc., a global leader in the medical aesthetics market, today announced results for the first quarter ended March 31, 2012. Revenue for the first quarter was $32.5 million, an increase of $6.0 million, or 23%, as compared to the first quarter of 2011.

2 May 2012

Blood services workers on strike in Michigan, Ohio

The American Red Cross is viciously attacking its workforce in the Midwest. More than 300 qualified, hardworking unionized blood services workers remain on strike over plans by Red Cross that would destabilize blood supply safety and strip workers of their collective bargaining rights.

2 May 2012

Medical News

First anniversary of Capital BlueCross' Accountable Care Arrangement programs

Misleading information about breast brachytherapy

Health Care REIT completes acquisition with Chartwell Seniors Housing REIT

Kindred Healthcare first quarter consolidated revenues increase 33% to $1.6 billion

German BfArM grants Moberg Derma approval to initiate Limtop phase II actinic keratosis trial

Levetiracetam to be tested for seizure management in malaria endemic regions

Optimum blood vitamin D levels to reduce risk of major medical events

It's never too late to take control of diabetes

Online assessment tool for stroke

Grape-derived compound may prevent neurodegenerative disorders involving tau neuropathology

Biosynthetic polyphenol may improve cognitive function in Alzheimer's disease patients

Medical Brands' cranberry-based oral capsule granted Class IIa medical device status

ImmuVen awarded $1.68M NIH Phase II SBIR grant to develop IMV0123

Older Americans experience significant and troubling gaps in primary care

Expression of tyrosine kinases may limit effectiveness of agents against sarcomas

Nanocomposite dental cavity-filling kills harmful bacteria

Lobbyists drive up taxpayer costs by obstructing state efforts to reform Medicaid drug programs

Acute need for more effective treatments for pediatric obesity

Solta Medical first quarter revenue increases 23% to $32.5 million

Blood services workers on strike in Michigan, Ohio

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News